FDA Says Bye to Checks: Go Digital for Payments
Published Date: 6/27/2025
Notice
Summary
Starting October 1, 2025, the FDA is ditching paper payments like checks and money orders for most federal payments and collections. If you work with the FDA on payments, get ready to switch to electronic methods—paper will only be allowed in rare cases. This change makes paying and collecting money faster and safer for everyone involved!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
FDA ends paper payments October 1, 2025
Starting October 1, 2025, the FDA will stop accepting paper-based payments and collections such as checks, bank drafts, and money orders except in limited cases with an exemption or waiver. If you work with the FDA on payments or collections, you must switch to electronic payment methods by that date.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20441, Medical Devices; Cardiovascular Devices; Classification of the Hyperoxia Monitoring Device Adjunct to Pulse Oximetry
The FDA is officially putting the hyperoxia monitoring device that works with pulse oximeters into a safer, easier-to-manage category called Class II. This change, effective October 6, 2026, means the device will have special safety rules but fewer regulatory hurdles, helping patients get access to this cool tech faster. Medical device makers and healthcare providers will feel the impact, with smoother approval processes and no big new costs expected.
Previous / Next Documents
Previous: 2025-11919, Agency Information Collection Activities: Requests for Comments; Clearance of a Renewed Approval of Information Collection
The FAA wants to keep collecting info from airlines to help spot safety risks and plan inspections better. They’re asking the public to share thoughts before they get official approval to continue. This process won’t cost extra but helps keep air travel safe and smooth.
Next: 2025-11921, Notice of Adoption of Categorical Exclusion Under Section 109 of the National Environmental Policy Act
The Department of the Interior is giving the Bureau of Indian Affairs a green light to use a special shortcut for building sanitation facilities in Indian communities. This means faster approvals for projects that improve homes and health without extra paperwork. It’s a win for tribes, speeding up important work while keeping the environment safe.